Zhenxian Lin

Zhenxian Lin

Auto-generated profile, based on publicly available information

Zhenxian Lin

Taishan Univ, Coll Life Sci & Enol, Lab Anim Genet Breeding & Reprod, Tai An 271018, Shandong, Peoples R China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Science of The Total Environment
Verified
Journal Article
Closed access
XLXuefu Li
Xuefu Li
SRShaoguo Ru
Shaoguo Ru
Hua TianHua Tian
Hua Tian
SZSuqiu Zhang
Suqiu Zhang
ZLZhenxian Lin
Zhenxian Lin
JWJun Wang
Jun Wang

12 December 2023 in Phytomedicine
Verified
Journal Article
Closed access
JLJingbo Liu
Jingbo Liu
KLKun Li
Kun Li
SLSong Li
Song Li
GYGuangcheng Yang
Guangcheng Yang
ZLZhenxian Lin
Zhenxian Lin
ZMZengmin Miao
Zengmin Miao

1 January 2022 in Chemosphere
Verified
Journal Article
Closed access
XLXuefu Li
Xuefu Li
JWJun Wang
Jun Wang
WBWanyu Ba
Wanyu Ba
SZSuqiu Zhang
Suqiu Zhang
ZLZhenxian Lin
Zhenxian Lin
SRShaoguo Ru
Shaoguo Ru

12 April 2024 in Poultry Science
Verified
Journal Article
Open access
JZJianmei Zhang
Jianmei Zhang
GYGuangcheng Yang
Guangcheng Yang
JLJingbo Liu
Jingbo Liu
ZLZhenxian Lin
Zhenxian Lin
JZJie Zhang
Jie Zhang
HLHai Lin
Hai Lin
Previously, we reported that glucagonlike peptide-1 ( GLP-1 ) and its analog liraglutide could inhibit fat de novo synthesis in the liver and reduce abdominal fat accumulation in broiler chickens. Nevertheless, the impact of GLP-1 on adipocyte fat deposition remains enigmatic. This study aimed to investigate the effects of GLP-1, via its analog liraglutide, on chicken chicken adipocytes in vitro. Chemical assays, quantitative real-time polymerase chain reaction ( qRT-PCR ), and western blot were employed to assess the proliferation, differentiation, and fat deposition of chicken adipocytes. Our findings indicated that liraglutide significantly suppressed cell proliferation and promoted preadipocyte differentiation in comparison to the control group. This was evidenced by elevated triglyceride (TG) TG ) content and upregulated mRNA expression of lipogenesis-related enzymes, such as acetyl-CoA carboxylase ( ACC) and fatty acid synthase ( FAS) , as well as regulators including peroxisome proliferator-activated receptor g (PPARg), PPAR g), sterol regulatory element binding protein-1 ( SREBP1 ) and CCAAT/enhancer binding protein a (CEBPa). CEBP a). In mature adipocytes, liraglutide attenuated fat deposition by inhibiting fat de novo synthesis, evidenced by decreased mRNA expression of ACC, FAS, PPARg, C/EBPa, and SREBP1, and concurrent upregulation of phosphorylated AMP-activated protein kinase ( p-AMPK ) and phosphorylated ACC (p p-ACC). ). This resulted in reduced accumulation of lipid droplets and TG content in mature adipocytes. Collectively, our findings indicate that liraglutide suppresses the proliferation of preadipocytes, enhances their differentiation, and concurrently inhibits de novo lipogenesis in mature adipocytes. This observation offers profound insights into the mechanisms that underlie liraglutide's anti-adipogenic effects, which could have significant implications for the treatment of obesity in broiler chickens.